Carcinoma, Neuroendocrine
"Carcinoma, Neuroendocrine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)
Descriptor ID |
D018278
|
MeSH Number(s) |
C04.557.465.625.650.240 C04.557.470.200.025.370 C04.557.580.625.650.240
|
Concept/Terms |
Carcinoma, Neuroendocrine- Carcinoma, Neuroendocrine
- Carcinomas, Neuroendocrine
- Neuroendocrine Carcinoma
- Neuroendocrine Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Neuroendocrine".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Neuroendocrine".
This graph shows the total number of publications written about "Carcinoma, Neuroendocrine" by people in this website by year, and whether "Carcinoma, Neuroendocrine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 1 | 2 |
1999 | 4 | 1 | 5 |
2000 | 2 | 0 | 2 |
2001 | 1 | 1 | 2 |
2002 | 1 | 1 | 2 |
2003 | 3 | 0 | 3 |
2004 | 4 | 0 | 4 |
2005 | 2 | 1 | 3 |
2006 | 3 | 0 | 3 |
2007 | 8 | 0 | 8 |
2008 | 6 | 2 | 8 |
2009 | 2 | 2 | 4 |
2010 | 6 | 2 | 8 |
2011 | 11 | 6 | 17 |
2012 | 5 | 2 | 7 |
2013 | 6 | 4 | 10 |
2014 | 8 | 9 | 17 |
2015 | 9 | 2 | 11 |
2016 | 15 | 0 | 15 |
2017 | 15 | 2 | 17 |
2018 | 9 | 3 | 12 |
2019 | 9 | 1 | 10 |
2020 | 11 | 2 | 13 |
2021 | 11 | 3 | 14 |
2022 | 9 | 2 | 11 |
2023 | 13 | 0 | 13 |
2024 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Neuroendocrine" by people in Profiles.
-
Neuroendocrine neoplasms of the ovary: a review of 63 cases. Int J Gynecol Cancer. 2024 Apr 01; 34(4):566-573.
-
Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Apr 01; 31(4).
-
Thyroid Cancer: A Review. JAMA. 2024 02 06; 331(5):425-435.
-
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study. Thyroid. 2024 01; 34(1):26-40.
-
Medullary Thyroid Carcinoma: Why are One in Four Patients Treated Out of Concordance from the ATA Guidelines? Ann Surg Oncol. 2024 02; 31(2):709-710.
-
Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer. Head Neck. 2024 Feb; 46(2):328-335.
-
PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study. Int J Gynecol Cancer. 2023 11 06; 33(11):1690-1694.
-
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract. Eur Urol Oncol. 2023 12; 6(6):611-620.
-
Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study. Int J Gynecol Cancer. 2023 09 04; 33(9):1359-1369.
-
Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study. Breast Cancer Res Treat. 2023 Nov; 202(1):23-32.